Advertisement

Topics

Schering Aktiengesellschaft Company Profile

20:19 EDT 17th June 2018 | BioPortfolio

As a successful pharmaceutical company, we are investing in the future of medicine. We develop drugs of high medical value so as to continuously improve the quality of life.
We make the most of knowledge. Using interdisciplinary networks we build bridges to academic researchers around the world, as well as to highly specialized biotech pioneers and partners in the pharmaceutical industry. We combine our own longstanding medical and pharmaceutical expertise with the latest discoveries from genomic research. Throughout, our research focuses on a meaningful combination of early diagnosis, prevention, treatment and therapy control.

We focus on our chosen fields of expertise:

Gynecology & Andrology
Oncology
Diagnostic Imaging
Specialized Therapeutics
As a global player with over 140 subsidiaries we are in close contact with our customers around the world.

Location

Müllerstr. 178
Berlin
13353
Germany

Contact

Phone: 49 30 468 11 11
Fax: 49 30 468 15 305


News Articles [36 Associated News Articles listed on BioPortfolio]

DGAP-Stimmrechte: Bayer Aktiengesellschaft (deutsch)

Bayer Aktiengesellschaft: Veröffentlichung gemäß § 40 Abs. 1 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Stimmrechtsmitteilung: Bayer Aktiengesellschaft Bayer Aktiengesellschaft: Veröffen...

DGAP-Gesamtstimmrechtsmitteilung: Bayer Aktiengesellschaft (deutsch)

Bayer Aktiengesellschaft: Veröffentlichung der Gesamtzahl der Stimmrechte nach § 41 WpHG mit dem Ziel der europaweiten Verbreitung DGAP Gesamtstimmrechtsmitteilung: Bayer Aktiengesellschaft / Verö....

DGAP-Adhoc: Bayer Aktiengesellschaft: Temasek zeichnet Kapitalerhöhung und erwirbt ca. 3,6 Prozent an Bayer (deutsch)

Bayer Aktiengesellschaft: Temasek zeichnet Kapitalerhöhung und erwirbt ca. 3,6 Prozent an Bayer DGAP-Ad-hoc: Bayer Aktiengesellschaft / Schlagwort(e): Kapitalmaßnahme Bayer Aktiengesellschaft: Tem.....

DGAP-HV: STADA Arzneimittel Aktiengesellschaft: -4-

DJ DGAP-HV: STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 02.02.2018 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG ....

DGAP-HV: STADA Arzneimittel Aktiengesellschaft: -2-

DJ DGAP-HV: STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 02.02.2018 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG ....

DGAP-HV: STADA Arzneimittel Aktiengesellschaft: -3-

DJ DGAP-HV: STADA Arzneimittel Aktiengesellschaft: Bekanntmachung der Einberufung zur Hauptversammlung am 02.02.2018 in Frankfurt am Main mit dem Ziel der europaweiten Verbreitung gemäß §121 AktG ....

Evotec plant eine Umwandlung

Evotec will seine Rechtsform ändern. Aus der bisherigen Aktiengesellschaft soll eine Europäische Aktiengesellschaft, kurz SE, werden. Vorstand und Aufsichtsrat sind für diese Umwandlung. Das letzte...

DGAP-AFR: Bayer Aktiengesellschaft: Vorabbekanntmachung über die Veröffentlichung von Finanzberichten gemäß § 114, 115, 117 WpHG

Dow Jones hat von EQS/DGAP eine Zahlung für die Verbreitung dieser Pressemitteilung über sein Netzwerk erhalten. DGAP Vorabbekanntmachung Finanzberichte: Bayer Aktiengesellschaft / Vorabbekanntmach....

PubMed Articles [0 Results]

None

Clinical Trials [13 Associated Clinical Trials listed on BioPortfolio]

Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis

The primary objective of this study is to evaluate the clinical efficacy of the drug Cloratadd D ® (loratadine + pseudoephedrine sulfate - EMS S/A) compared to the drug Claritin D ® (lor...

Bioequivalence Study of 120 mg Etoricoxib Film-coated Tablets

The present study was a randomized, open-label, two-period, two-sequence, cross-over study, conducted to find out whether the etoricoxib 120 mg film-coated tablet produced by PT Dexa Medic...

Remicade Infusion Management Program (Study P04466)

Schering Canada plans to collect data on about 3000 to 5000 infliximab infusions per year, starting in the third quarter of 2005. It is expected that about 12 sites from the Remicade Infu...

Bioequivalence Study on Loratadine Orally Disintegrating Tablets 10 mg Under Fasting Conditions

To compare the single-dose oral bioavailability of loratadine 10 mg orally disintegrating tablets of Ohm Laboratories (a subsidiary of Ranbaxy Pharmaceuticals Inc., USA) with Claritin® Re...

Bioequivalence Study of Loratadine / Pseudoephedrine Sulfate 10/ 240 mg Extended-Release Tablets Under Fed Conditions

The objective of this study was to compare the single-dose relative bioavailability of Ranbaxy and Schering (Claritin-D® 24 hour) 10 mg Loratadine/240 mg Pseudoephedrine Sulfate Extended-...

Companies [46 Associated Companies listed on BioPortfolio]

Schering Health Care Limited

Schering Health Care is the UK subsidiary of Schering AG, an international pharmaceutical company with headquarters located in Berlin, Germany.Schering is a global company, with over 150 subsidiaries ...

Schering-Plough Corp.

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies th...

Intervet/Schering-Plough Animal Health

Intervet/Schering-Plough Animal Health, based in Boxmeer, the Netherlands, is focused on the research, development, manufacturing and marketing of animal health products. The company offers customers ...

Schering Aktiengesellschaft

As a successful pharmaceutical company, we are investing in the future of medicine. We develop drugs of high medical value so as to continuously improve the quality of life.We make the most of knowled...

B-R-A-H-M-S Aktiengesellschaft

More Information about "Schering Aktiengesellschaft" on BioPortfolio

We have published hundreds of Schering Aktiengesellschaft news stories on BioPortfolio along with dozens of Schering Aktiengesellschaft Clinical Trials and PubMed Articles about Schering Aktiengesellschaft for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Schering Aktiengesellschaft Companies in our database. You can also find out about relevant Schering Aktiengesellschaft Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record